The scientist’s investigation covers issues in Genetics, Comparative genomic hybridization, Gene, Breast cancer and Gene expression profiling. Genome, Genomics, Human genome, DNA repair and Gene dosage are the subjects of his Genetics studies. His work deals with themes such as Gene duplication, CDKN2A, Karyotype and Candidate gene, which intersect with Comparative genomic hybridization.
His research links Erbb2 her2 with Gene. The Breast cancer study combines topics in areas such as BRCA2 Protein, Cancer research and Germline. His biological study spans a wide range of topics, including Survival rate, Cancer, Surgical oncology and Bioinformatics.
His main research concerns Cancer research, Internal medicine, Genetics, Breast cancer and Oncology. His study in the fields of Melanoma under the domain of Cancer research overlaps with other disciplines such as PTEN. All of his Genetics and Comparative genomic hybridization, Gene, Genome, Gene duplication and Mutation investigations are sub-components of the entire Genetics study.
As part of one scientific family, he deals mainly with the area of Comparative genomic hybridization, narrowing it down to issues related to the Molecular biology, and often Chromosome. His studies in Genome integrate themes in fields like Germline mutation and Mutation rate. His research in Breast cancer intersects with topics in Surgical oncology and Gene expression profiling.
Johan Staaf mainly focuses on Internal medicine, Oncology, Lung cancer, Cancer research and Breast cancer. He interconnects Stage, Triple-negative breast cancer, Survival analysis and Receiver operating characteristic in the investigation of issues within Oncology. His Lung cancer research incorporates elements of Population based, Epigenetics and Gene expression, DNA methylation.
His Cancer research research integrates issues from Cell, Gene, Exon and Digital droplet pcr. The concepts of his Gene study are interwoven with issues in Osteosarcoma and Preprocessor. Breast cancer is a primary field of his research addressed under Cancer.
His primary areas of investigation include DNA methylation, Internal medicine, Oncology, Lung cancer and Cancer research. His study in DNA methylation is interdisciplinary in nature, drawing from both Biomarker, Methylation and Hazard ratio. His Oncology research includes elements of Radiosensitivity and Chemotherapy.
His Lung cancer research is multidisciplinary, incorporating perspectives in Transcriptome, Gene expression, Carcinoma and Adenocarcinoma. He has included themes like Cell, Gene and Lung in his Cancer research study. Johan Staaf combines subjects such as Computational biology and Disease with his study of Breast cancer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Serena Nik-Zainal;Serena Nik-Zainal;Helen Davies;Johan Staaf;Manasa Ramakrishna.
Nature (2016)
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
Helen Davies;Dominik D. Glodzik;Sandro S. Morganella;Lucy R. Yates.
Nature Medicine (2017)
Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair
Lao H Saal;Sofia K Gruvberger-Saal;Camilla Persson;Kristina Lövgren.
Nature Genetics (2008)
GOBO: Gene Expression-Based Outcome for Breast Cancer Online.
Markus Ringnér;Erik Fredlund;Jari Häkkinen;Åke Borg.
PLOS ONE (2011)
Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns
Karolina Holm;Cecilia Hegardt;Johan Staaf;Johan Vallon-Christersson.
Breast Cancer Research (2010)
MiRNA expression in urothelial carcinomas: Important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31.
Srinivas Veerla;David Lindgren;Anders Kvist;Attila Frigyesi.
International Journal of Cancer (2009)
Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics
Göran B Jönsson;Johan Staaf;Johan Vallon-Christersson;Markus Ringnér.
Breast Cancer Research (2010)
High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.
Göran B Jönsson;Johan Staaf;Eleonor Olsson;Markus Heidenblad.
Genes, Chromosomes and Cancer (2007)
Identification of Subtypes in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Reveals a Gene Signature Prognostic of Outcome
Johan Staaf;Markus Ringnér;Johan Vallon-Christersson;Göran Jönsson.
Journal of Clinical Oncology (2010)
Identification of New MicroRNAs in Paired Normal and Tumor Breast Tissue Suggests a Dual Role for the ERBB2/Her2 Gene
Helena Persson;Anders Kvist;Natalia Rego;Johan Staaf.
Cancer Research (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Lund University
Lund University
Skåne University Hospital
University of Cambridge
Lund University
Harvard University
University of Cambridge
University of Queensland
Lund University
Oslo University Hospital
University of Southampton
New Jersey Institute of Technology
East China Normal University
Global HIV Vaccine Enterprise
University of Copenhagen
Parco Tecnologico Padano
Iowa State University
Virginia Institute of Marine Science
Rockefeller University
New York University
University of Birmingham
Pennsylvania State University
University of Utah
Sorbonne University
Institute of Tropical Medicine Antwerp
Georgia Institute of Technology